Literature DB >> 19151772

Fully functional NK cells after unrelated cord blood transplantation.

V Beziat1, S Nguyen, S Lapusan, B Hervier, N Dhedin, D Bories, M Uzunov, A Boudifa, H Trebeden-Negre, F Norol, Z Marjanovic, J-P Marie, J-P Vernant, P Debre, B Rio, V Vieillard.   

Abstract

Promising results of umbilical cord blood transplantation (UCBT) from unrelated donors have been reported in patients with hematologic disorders. These transplants, having potential to trigger beneficial donor-versus-recipient natural killer (NK) cell-mediated alloreaction, we have conducted the first extensive analysis of the phenotypic and functional properties of NK cells after UCBT. NK cells from 25 patients with high-risk hematologic malignancies were compared with cells derived from both healthy adult and CB cells. We found that following UCBT, NK cells display not only some phenotypic features associated with maturity but also unique characteristics that make them fully functional against leukemic blasts. We propose that this full functionality of alloreactive donor-derived NK may drive graft-versus-leukemia reactions after UCBT.

Entities:  

Mesh:

Year:  2009        PMID: 19151772     DOI: 10.1038/leu.2008.343

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


  16 in total

Review 1.  Umbilical cord blood immunology: relevance to stem cell transplantation.

Authors:  Syh-Jae Lin; Dah-Chin Yan; Yen-Chang Lee; Hsiu-Shan Hsiao; Pei-Tzu Lee; Yu-Wen Liang; Ming-Ling Kuo
Journal:  Clin Rev Allergy Immunol       Date:  2012-02       Impact factor: 8.667

2.  Expression of chimeric receptor CD4ζ by natural killer cells derived from human pluripotent stem cells improves in vitro activity but does not enhance suppression of HIV infection in vivo.

Authors:  Zhenya Ni; David A Knorr; Laura Bendzick; Jeremy Allred; Dan S Kaufman
Journal:  Stem Cells       Date:  2014-04       Impact factor: 6.277

3.  Phenotypic and functional activation of hyporesponsive KIRnegNKG2Aneg human NK-cell precursors requires IL12p70 provided by Poly(I:C)-matured monocyte-derived dendritic cells.

Authors:  Shane A Curran; Emanuela Romano; Michael G Kennedy; Katharine C Hsu; James W Young
Journal:  Cancer Immunol Res       Date:  2014-07-14       Impact factor: 11.151

4.  CD11b and CD27 reflect distinct population and functional specialization in human natural killer cells.

Authors:  Binqing Fu; Fuyan Wang; Rui Sun; Bin Ling; Zhigang Tian; Haiming Wei
Journal:  Immunology       Date:  2011-04-21       Impact factor: 7.397

Review 5.  Interaction between natural killer cells and regulatory T cells: perspectives for immunotherapy.

Authors:  Isabela Pedroza-Pacheco; Alejandro Madrigal; Aurore Saudemont
Journal:  Cell Mol Immunol       Date:  2013-03-25       Impact factor: 11.530

6.  Fewer Circulating Natural Killer Cells 28 Days After Double Cord Blood Transplantation Predicts Inferior Survival and IL-15 Response.

Authors:  Rachel J Bergerson; Robin Williams; Hongbo Wang; Ryan Shanley; Gretchen Colbenson; Alyssa Kerber; Sarah Cooley; Julie Curtsinger; Martin Felices; Jeffrey S Miller; Michael R Verneris
Journal:  Blood Adv       Date:  2016-10-30

7.  Clinical impact of NK-cell reconstitution after reduced intensity conditioned unrelated cord blood transplantation in patients with acute myeloid leukemia: analysis of a prospective phase II multicenter trial on behalf of the Société Française de Greffe de Moelle Osseuse et Thérapie Cellulaire and Eurocord.

Authors:  S Nguyen; A Achour; L Souchet; S Vigouroux; P Chevallier; S Furst; A Sirvent; J-O Bay; G Socié; P Ceballos; A Huynh; J Cornillon; S Francois; F Legrand; I Yakoub-Agha; G Michel; N Maillard; G Margueritte; S Maury; M Uzunov; C-E Bulabois; M Michallet; L Clement; C Dauriac; K Bilger; J Lejeune; V Béziat; V Rocha; B Rio; S Chevret; V Vieillard
Journal:  Bone Marrow Transplant       Date:  2017-06-26       Impact factor: 5.483

8.  NK cell terminal differentiation: correlated stepwise decrease of NKG2A and acquisition of KIRs.

Authors:  Vivien Béziat; Benjamin Descours; Christophe Parizot; Patrice Debré; Vincent Vieillard
Journal:  PLoS One       Date:  2010-08-06       Impact factor: 3.240

Review 9.  Cellular engineering and therapy in combination with cord blood allografting in pediatric recipients.

Authors:  M S Cairo; N Tarek; D A Lee; C Delaney
Journal:  Bone Marrow Transplant       Date:  2015-09-14       Impact factor: 5.483

10.  Role for early-differentiated natural killer cells in infectious mononucleosis.

Authors:  Tarik Azzi; Anna Lünemann; Anita Murer; Seigo Ueda; Vivien Béziat; Karl-Johan Malmberg; Georg Staubli; Claudine Gysin; Christoph Berger; Christian Münz; Obinna Chijioke; David Nadal
Journal:  Blood       Date:  2014-09-09       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.